VRAY on NASDAQ

ViewRay

Logo: viewray.com⁴

ViewRay is a medical technology company based in Cleveland, Ohio, founded in 2004.¹ Its shares trade on NASDAQ under the symbol VRAY.¹

Price unavailable

Last updated Oct 21, 2026.

Overview

2004Founded¹

Compare with BIOLIFE SOLUTIONS INC, VASO Corp or Ceribell, Inc., or pick any stock.

TickerVRAY on NASDAQ¹
IndustryElectromedical & Electrotherapeutic Apparatus¹
HeadquartersCleveland¹
Websiteviewray.com
Incorporated inDE⁵
Business address2 Thermo Fisher Way, Oakwood Village, Oh 44146⁵
Legal formProfit Corporation³
LEI5493006XTUBSKFU3W106³
StatusActive³
LEI statusLapsed (not renewed)³
Registered addressC/O Business Filings Incorporated, 89703 Carson City, United States³

See how the biggest companies compare on our leaderboards

ViewRay image from its website — Image: viewray.com⁴

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

9.8%Gross margin⁶

-104.8%Operating margin⁶

-105.0%Net margin⁶

45.8%Revenue growth, 2022⁶

-130.5%Return on equity⁶

0.89×Debt to equity⁶

-$95.6MFree cash flow⁶

Where the money goes

Where each dollar of revenue went, fiscal 2022

Cost of revenueResearch and development

Cost of revenue71¢$92.2M
Research and development25¢$32.4M
Interest4¢$5.1M

Out of $102.2M in revenue.⁶ The company lost money this year.

Financial statements

Revenue⁷⁸⁹¹⁰⁶$102.2M in 2022+360% since 2016

Gross profit⁷⁸⁹¹⁰⁶$10.0M in 2022

Operating income⁷⁸⁹¹⁰⁶-$107.1M in 2022+143% since 2016

Net income⁷⁸⁹¹⁰⁶-$107.3M in 2022+112% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Revenue	$22.2M⁷	$34.0M⁸	$81.0M⁹	$87.8M¹⁰	$57.0M⁶	$70.1M⁶	$102.2M⁶
Cost of revenue	$25.9M¹⁴	$27.7M¹⁴	$74.4M⁹	$93.3M¹⁰	$61.1M⁶	$69.8M⁶	$92.2M⁶
Gross profit	-$3.6M⁷	$6.3M⁸	$6.6M⁹	-$5.5M¹⁰	-$4.1M⁶	$335.0K⁶	$10.0M⁶
Research and development	$11.4M⁷	$14.7M⁸	$16.5M⁹	$23.8M¹⁰	$25.0M⁶	$31.8M⁶	$32.4M⁶
Selling, general and admin
Operating expenses						$104.0M⁶	$117.2M⁶
Operating income	-$44.2M⁷	-$48.2M⁸	-$75.1M⁹	-$120.8M¹⁰	-$106.0M⁶	-$103.6M⁶	-$107.1M⁶
Interest	$6.0M⁷	$7.2M⁸	$7.7M⁹	$4.3M¹⁰	$3.3M⁶	$4.2M⁶	$5.1M⁶
Income before tax						-$110.0M⁶	-$107.3M⁶
Income tax	$0⁷	$0⁸	$0⁹	$0¹⁰	$0⁶	$0⁶	$0⁶
Net income	-$50.6M⁷	-$72.2M⁸	-$76.4M⁹	-$120.2M¹⁰	-$107.9M⁶	-$110.0M⁶	-$107.3M⁶
Earnings per share				-$1.18¹⁰	-$0.73⁶	-$0.67⁶	-$0.59⁶
Earnings per share (diluted)				-$1.18¹⁰	-$0.73⁶	-$0.67⁶	-$0.59⁶
Shares (weighted, basic)						164.5M shares⁶	180.7M shares⁶
Shares (weighted, diluted)						164.5M shares⁶	180.7M shares⁶

Total assets¹⁴⁷⁸⁹¹⁰⁶$271.4M in 2022+457% since 2016

Total liabilities¹⁴⁷⁸⁹¹⁰⁶$189.2M in 2022+105% since 2016

Shareholders’ equity⁸⁹¹⁰⁶$82.2M in 2022

Cash¹⁴⁷⁸⁹¹⁰⁶$136.0M in 2022+858% since 2016

Long-term debt¹⁴⁷⁸⁹¹⁰⁶$73.3M in 2022+66% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Cash	$14.2M¹⁴	$57.4M⁷	$167.4M⁸	$226.8M⁹	$156.7M¹⁰	$218.3M⁶	$136.0M⁶
Receivables						$21.7M⁶	$41.4M⁶
Inventory						$29.6M⁶	$31.3M⁶
Current assets	$35.9M¹⁴	$122.7M⁷	$277.7M⁸	$311.9M⁹	$224.4M¹⁰	$283.5M⁶	$228.4M⁶
Property, plant and equipment						$20.2M⁶	$19.6M⁶
Intangible assets						$44.0K⁶	$38.0K⁶
Total assets	$48.8M¹⁴	$135.7M⁷	$295.0M⁸	$350.0M⁹	$261.6M¹⁰	$321.8M⁶	$271.4M⁶
Accounts payable						$9.2M⁶	$28.3M⁶
Short-term debt						$3.2M⁶	$0⁶
Current liabilities	$37.2M¹⁴	$56.2M⁷	$53.9M⁸	$59.1M⁹	$56.9M¹⁰	$76.2M⁶	$96.6M⁶
Long-term debt	$44.3M¹⁴	$44.5M⁷	$55.4M⁸	$54.0M⁹	$56.9M¹⁰	$54.0M⁶	$73.3M⁶
Total liabilities	$92.4M¹⁴	$133.7M⁷	$127.7M⁸	$133.8M⁹	$131.3M¹⁰	$152.0M⁶	$189.2M⁶
Retained earnings						-$737.1M⁶	-$844.5M⁶
Shareholders’ equity	-$43.7M⁸	$2.0M⁹	$167.3M¹⁰	$216.2M⁶	$130.3M⁶	$169.8M⁶	$82.2M⁶
Shares outstanding	43.6M shares¹⁴	67.7M shares⁷	96.3M shares⁸	147.2M shares⁹	148.6M shares¹⁰	179.2M shares⁶	181.6M shares⁶

Cash from operations⁷⁸⁹¹⁰⁶-$91.7M in 2022+226% since 2016

Capital spending⁷⁸⁹¹⁰⁶$3.9M in 2022−45% since 2016

Free cash flow⁷⁸⁹¹⁰⁶-$95.6M in 2022+172% since 2016

Fiscal year	2016	2017	2018	2019	2020	2021	2022
Cash from operations	-$28.2M⁷	-$70.1M⁸	-$122.2M⁹	-$79.6M¹⁰	-$63.5M⁶	-$62.1M⁶	-$91.7M⁶
Depreciation and amortization						$6.0M⁶	$4.9M⁶
Stock-based compensation						$23.9M⁶	$21.6M⁶
Capital spending	$7.0M⁷	$2.2M⁸	$3.7M⁹	$7.8M¹⁰	$6.2M⁶	$1.6M⁶	$3.9M⁶
Free cash flow	-$35.2M	-$72.2M	-$125.9M	-$87.3M	-$69.7M	-$63.6M	-$95.6M
Cash from investing						-$1.6M⁶	-$3.9M⁶
Cash from financing						$125.3M⁶	$18.3M⁶

Compare ViewRay with another company

Corporate structure

ViewRay sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ViewRay

PURA VIDA INVESTMENTS, LLC Filed SC 13G/A on ViewRay, latest Feb 14, 2024 (3 filings since Feb 14, 2022)
Artisan Partners Limited Partnership Filed SC 13G/A on ViewRay, latest Feb 12, 2024 (3 filings since Feb 4, 2022)
Fosun International Ltd Filed SC 13G/A on ViewRay, latest Feb 7, 2024 (3 filings since Nov 10, 2021)
BlackRock Filed SC 13G/A on ViewRay, latest Aug 8, 2023 (3 filings since Feb 4, 2022)
Farhad Fred Ebrahimi Filed SC 13D/A on ViewRay, latest Jul 25, 2023 (3 filings since Apr 27, 2023)
Hudson Executive Capital LP Filed SC 13D/A on ViewRay, latest Jul 21, 2023 (3 filings since Mar 9, 2022)
Neuberger Berman Filed SC 13G/A on ViewRay, latest Jul 6, 2023 (2 filings since Feb 10, 2023)
VANGUARD GROUP INC Filed SC 13G on ViewRay, latest Feb 9, 2023
MILLENNIUM MANAGEMENT LLC Filed SC 13G/A on ViewRay, latest Jan 25, 2023 (2 filings since Mar 9, 2022)
FMR LLC Filed SC 13G/A on ViewRay, latest Apr 11, 2022 (2 filings since Feb 9, 2022)

ViewRay Moscow, Russia

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Leadership

Who has led ViewRay, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

Chief operating officer

20052010201520202025

Chief executive officerPaul Ziegler Jr. Jul 18, 2023 to Jul 21, 2023¹⁵
Chief executive officerScott William Drake Jul 24, 2018 to Jun 16, 2023¹⁶
Chief executive officerChris Raanes Mar 30, 2016 to May 16, 2018¹⁷
PresidentScott William Drake Jul 24, 2018 to Jun 16, 2023¹⁶
PresidentChris Raanes Mar 30, 2016 to May 16, 2018¹⁷
Chief financial officerWillaim P. Burke Jan 12, 2023 to Mar 3, 2023¹⁸
Chief financial officerJacob Edward Signoriello May 22, 2023 to May 22, 2023¹⁹
Chief financial officerZachary William Stassen May 22, 2020 to Jun 2, 2022²⁰
Chief financial officerBrian Knaley Oct 10, 2019 to Mar 3, 2020²¹
Chief financial officerD. David Chandler Mar 30, 2016 to Mar 30, 2016²²
Chief financial officerAjay Bansal Jun 16, 2016 to Jul 29, 2019²³
Chief operating officerShahriar Matin Jul 24, 2018 to Mar 3, 2021²⁴
Chief operating officerDouglas Keare Mar 30, 2016 to Apr 18, 2018²⁵

Board members and other officers (27)

SVP, Customer ServicesAdam Andrew Podbelski Jul 26, 2023 to Jul 26, 2023²⁶
Chief Commercial OfficerPaul Ziegler Jr. Jun 15, 2021 to Jun 16, 2023²⁷
SVP Gen Counsel & Corp SecRobert S. McCormack Jun 15, 2021 to Mar 3, 2023²⁸
Chief Commercial OfficerJames Alecxih Sep 28, 2018 to Oct 28, 2019²⁹
Chief Scientific OfficerJames F. Dempsey Mar 30, 2016 to Mar 21, 2023³⁰
Board memberSusan C. Schnabel Mar 10, 2022 to Jan 4, 2023³¹
Board memberPhillip M. Spencer Feb 11, 2021 to Jan 4, 2023³²
Board memberKaren Prange Jun 15, 2021 to Jul 21, 2023³³
Board memberB. Kristine Johnson Apr 23, 2020 to Jul 24, 2023³⁴
Board memberGail Wilensky Jul 26, 2019 to Jan 4, 2023³⁵
Board memberYili Kevin Xie Nov 7, 2019 to Jan 5, 2022³⁶
Board memberDaniel Jeffrey Moore Mar 5, 2018 to Jan 4, 2023³⁷
Board memberR. Scott Huennekens Mar 5, 2018 to Jun 17, 2020³⁸
Board memberScott William Drake Jul 24, 2018 to Jul 20, 2023¹⁶
Board memberD. Keith Grossman Aug 1, 2018 to Jan 5, 2021³⁹
Board memberTheodore T. Wang Jan 25, 2017 to Jan 3, 2019⁴⁰
Board memberAditya Puri Mar 30, 2016 to Jan 3, 2019⁴¹
Board memberBrian K. Roberts Mar 30, 2016 to Jun 15, 2022⁴²
Board memberCaley Castelein Mar 30, 2016 to Jul 21, 2023⁴³
Board memberChris Raanes Mar 30, 2016 to May 16, 2018¹⁷
Board memberDavid P. Bonita Mar 30, 2016 to Apr 25, 2018⁴⁴
Board memberJames F. Dempsey Mar 30, 2016 to Mar 3, 2020³⁰
Board memberJoshua H. Bilenker Mar 30, 2016 to Sep 15, 2016⁴⁵
Board memberMark Stephen Gold Mar 30, 2016 to Apr 25, 2018⁴⁶
Board memberHenry A. McKinnell Apr 13, 2016 to Jan 3, 2019⁴⁷
Board memberSamuel D. Isaly Aug 24, 2016 to Jan 20, 2017⁴⁸
General counselSanket Shah Jul 26, 2023 to Jul 26, 2023⁴⁹

Timeline

Sep 7, 20238-K Regulation FD disclosure⁵⁰
Aug 3, 20238-K Other events⁵¹
Jul 21, 20238-K Listing notice or transfer; Regulation FD disclosure⁵²
Jul 18, 2023New chief executive Paul Ziegler Jr. becomes CEO¹⁵
Jul 17, 20238-K Entered a material agreement; Bankruptcy or receivership; Debt or obligation accelerated⁵³
Jul 7, 20238-K Executive or director change⁵⁴
Jun 30, 20238-K Listing notice or transfer⁵⁵
May 10, 20238-K Results of operations; Regulation FD disclosure⁵⁶
Apr 13, 20238-K Results of operations; Regulation FD disclosure⁵⁷
Mar 14, 20238-K Regulation FD disclosure⁵⁸
Feb 27, 20238-K Results of operations; Regulation FD disclosure⁵⁹
Jan 20, 20238-K Entered a material agreement; Other events⁶⁰
Jan 9, 20238-K Results of operations; Executive or director change; Regulation FD disclosure⁶¹
Jul 24, 2018New chief executive Scott William Drake becomes CEO¹⁶
Mar 30, 2016New chief executive Chris Raanes becomes CEO¹⁷
2004Founded Founded¹

Calendar

When it reported results

May 10, 2023Reported quarterly or annual results⁵⁶
Apr 13, 2023Reported quarterly or annual results⁵⁷
Feb 27, 2023Reported quarterly or annual results⁵⁹
Jan 9, 2023Reported quarterly or annual results⁶¹
Nov 1, 2022Reported quarterly or annual results⁶²
Aug 2, 2022Reported quarterly or annual results⁶³
May 5, 2022Reported quarterly or annual results⁶⁴
Feb 24, 2022Reported quarterly or annual results⁶⁵

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

167 filings to the SEC since October 2021: 3 annual reports, 5 quarterly reports, 31 major events, 81 insider forms, 25 large holders, 22 other. The latest 20:

Feb 14, 2024SC 13G/A EDGAR
Feb 12, 2024SC 13G/A EDGAR
Feb 7, 2024SC 13G/A EDGAR
Sep 7, 20238-K EDGAR
Aug 14, 2023NT 10-Q EDGAR
Aug 8, 2023SC 13G/A EDGAR
Aug 3, 20238-K EDGAR
Jul 26, 20234 EDGAR
Jul 26, 20234 EDGAR
Jul 26, 20233 EDGAR
Jul 26, 20233 EDGAR
Jul 25, 2023144 EDGAR
Jul 25, 2023SC 13D/A EDGAR
Jul 24, 20234 EDGAR
Jul 21, 2023144 EDGAR
Jul 21, 2023144 EDGAR
Jul 21, 20234 EDGAR
Jul 21, 20234 EDGAR
Jul 21, 20234 EDGAR
Jul 21, 20238-K EDGAR

The 167 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

PURA VIDA INVESTMENTS, LLCSC 13G/A, 3 filings Feb 14, 2022 to Feb 14, 2024⁶⁶
Artisan Partners Limited PartnershipSC 13G/A, 3 filings Feb 4, 2022 to Feb 12, 2024⁶⁷
Fosun International LtdSC 13G/A, 3 filings Nov 10, 2021 to Feb 7, 2024⁶⁸
BlackRockSC 13G/A, 3 filings Feb 4, 2022 to Aug 8, 2023⁶⁹
Farhad Fred EbrahimiSC 13D/A, 3 filings Apr 27, 2023 to Jul 25, 2023⁷⁰
Hudson Executive Capital LPSC 13D/A, 3 filings Mar 9, 2022 to Jul 21, 2023⁷¹
Neuberger BermanSC 13G/A, 2 filings Feb 10, 2023 to Jul 6, 2023⁷²
VANGUARD GROUP INCSC 13G, 1 filing Feb 9, 2023⁷³
MILLENNIUM MANAGEMENT LLCSC 13G/A, 2 filings Mar 9, 2022 to Jan 25, 2023⁷⁴
FMR LLCSC 13G/A, 2 filings Feb 9, 2022 to Apr 11, 2022⁷⁵

SEC filer profile

How ViewRay is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARVIEWRAY INC²
CIK0001336705
Employer ID (EIN)20-0818429²
Incorporated inDelaware²
Fiscal year endsDecember 31²
Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus²
Business address2 Thermo Fisher Way, Oakwood Village, OH 44146²
Phone440-703-3210²
On EDGAR sinceAug 15, 2005²
Filings27 in all: D (8), S-1/A (7), D/A (2), DRS/A (2), REGDEX (2), 8-A12B (1), CERTNAS (1), DRS (1)²
All 11 form types
REGDEX/A (1), RW (1), S-1 (1)

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataViewRay on Wikidata
2
SEC EDGARViewRay filings on SEC EDGAR
3
GLEIFViewRay LEI record (5493006XTUBSKFU3W106)
4
Company websiteViewRay logo
5
SEC EDGARViewRay filings on SEC EDGAR
6
SEC EDGARViewRay 10-K for fiscal 2022
7
SEC EDGARViewRay 10-K for fiscal 2016
8
SEC EDGARViewRay 10-K for fiscal 2017
9
SEC EDGARViewRay 10-K for fiscal 2018
10
SEC EDGARViewRay 10-K for fiscal 2019
11
SEC EDGARViewRay 10-Q for fiscal 2022
12
SEC EDGARViewRay 10-Q for fiscal 2022
13
SEC EDGARViewRay 10-Q for fiscal 2023
14
SEC EDGARViewRay 10-K for fiscal 2016
15
SEC EDGARPaul Ziegler Jr., Chief executive officer
16
SEC EDGARScott William Drake, Chief executive officer
17
SEC EDGARChris Raanes, Chief executive officer
18
SEC EDGARWillaim P. Burke, Chief financial officer
19
SEC EDGARJacob Edward Signoriello, Chief financial officer
20
SEC EDGARZachary William Stassen, Chief financial officer
21
SEC EDGARBrian Knaley, Chief financial officer
22
SEC EDGARD. David Chandler, Chief financial officer
23
SEC EDGARAjay Bansal, Chief financial officer
24
SEC EDGARShahriar Matin, Chief operating officer
25
SEC EDGARDouglas Keare, Chief operating officer
26
SEC EDGARAdam Andrew Podbelski, SVP, Customer Services
27
SEC EDGARPaul Ziegler Jr., Chief Commercial Officer
28
SEC EDGARRobert S. McCormack, SVP Gen Counsel & Corp Sec
29
SEC EDGARJames Alecxih, Chief Commercial Officer
30
SEC EDGARJames F. Dempsey, Chief Scientific Officer
31
SEC EDGARSusan C. Schnabel, Board member
32
SEC EDGARPhillip M. Spencer, Board member
33
SEC EDGARKaren Prange, Board member
34
SEC EDGARB. Kristine Johnson, Board member
35
SEC EDGARGail Wilensky, Board member
36
SEC EDGARYili Kevin Xie, Board member
37
SEC EDGARDaniel Jeffrey Moore, Board member
38
SEC EDGARR. Scott Huennekens, Board member
39
SEC EDGARD. Keith Grossman, Board member
40
SEC EDGARTheodore T. Wang, Board member
41
SEC EDGARAditya Puri, Board member
42
SEC EDGARBrian K. Roberts, Board member
43
SEC EDGARCaley Castelein, Board member
44
SEC EDGARDavid P. Bonita, Board member
45
SEC EDGARJoshua H. Bilenker, Board member
46
SEC EDGARMark Stephen Gold, Board member
47
SEC EDGARHenry A. McKinnell, Board member
48
SEC EDGARSamuel D. Isaly, Board member
49
SEC EDGARSanket Shah, General counsel
50
SEC EDGARRegulation FD disclosure
51
SEC EDGAROther events
52
SEC EDGARListing notice or transfer; Regulation FD disclosure
53
SEC EDGAREntered a material agreement; Bankruptcy or receivership; Debt or obligation accelerated
54
SEC EDGARExecutive or director change
55
SEC EDGARListing notice or transfer
56
SEC EDGARResults of operations; Regulation FD disclosure
57
SEC EDGARResults of operations; Regulation FD disclosure
58
SEC EDGARRegulation FD disclosure
59
SEC EDGARResults of operations; Regulation FD disclosure
60
SEC EDGAREntered a material agreement; Other events
61
SEC EDGARResults of operations; Executive or director change; Regulation FD disclosure
62
SEC EDGARViewRay 8-K, Item 2.02 (results of operations)
63
SEC EDGARViewRay 8-K, Item 2.02 (results of operations)
64
SEC EDGARViewRay 8-K, Item 2.02 (results of operations)
65
SEC EDGARViewRay 8-K, Item 2.02 (results of operations)
66
SEC EDGARPURA VIDA INVESTMENTS, LLC SC 13G/A on ViewRay
67
SEC EDGARArtisan Partners Limited Partnership SC 13G/A on ViewRay
68
SEC EDGARFosun International Ltd SC 13G/A on ViewRay
69
SEC EDGARBlackRock SC 13G/A on ViewRay
70
SEC EDGARFarhad Fred Ebrahimi SC 13D/A on ViewRay
71
SEC EDGARHudson Executive Capital LP SC 13D/A on ViewRay
72
SEC EDGARNeuberger Berman SC 13G/A on ViewRay
73
SEC EDGARVANGUARD GROUP INC SC 13G on ViewRay
74
SEC EDGARMILLENNIUM MANAGEMENT LLC SC 13G/A on ViewRay
75
SEC EDGARFMR LLC SC 13G/A on ViewRay